產(chǎn)品展廳收藏該商鋪

您好 登錄 注冊

當前位置:
美國布魯克海文儀器公司>技術文章>測量應用案例-34-90Plus

技術文章

測量應用案例-34-90Plus

閱讀:275          發(fā)布時間:2015-6-2
 文獻名: Calcium phosphate nanocapsule crowned multiwalled carbon nanotubes for pH triggered intracellular anticancer drug release
 
作者:Shashwat S. Banerjee,a   Kiran J. Todkar,a   Ganesh V. Khutale,a   Govind P. Chate,b   Ankush V. Biradar,c   Manoj B. Gawande,d   Radek Zboril,d and  Jayant J. Khandareb
a Actorius Innovations and Research, 100 NCL Innovation Park, Pune-411008, India 
b Maharashtra Institute of Pharmacy, Maharashtra Institute of Technology Campus, Kothrud, Pune-411038, India 
c Catalysis Division, CSIR-National Chemical Laboratory, Pune-411008, India 
d Regional Centre of Advanced Technologies and Materials, Faculty of Science, Department of Physical Chemistry, Palacky University, Šlechti? 11, Olomouc, Czech Republic
 
摘要:We report calcium phosphate (CaP) nanocapsule crowned multiwalled carbon nanotubes (CNT–GSH–G4–CaP) as a novel platform for intracellular delivery of an anticancer drug. As a proof-of-concept, CNT–GSH–G4–CaP demonstrates release of anticancer drug doxorubicin hydrochloride (DOX) within intracellular lysosomes from the interior cavity of CNT upon pH triggered CaP dissolution. Importantly, we found that the CNT with a CaP nanolid can efficiently prevent untimely drug release at physiological pH but promotes DOX release at increased acidic milieu as observed in subcellular compartments such as lysosomes (5.0). This “zero premature release” characteristic is of clinical significance in delivering cytotoxic drugs, by reducing systemic toxicity and thus beneficial for the effective anticancer treatment. We envision that this pH triggered CaP crowned CNT nanosystem would lead to a new generation of self-regulated platforms for intracellular delivery of a variety of anticancer drugs.

收藏該商鋪

登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時間回復您~

對比框

產(chǎn)品對比 產(chǎn)品對比 聯(lián)系電話 二維碼 意見反饋 在線交流

掃一掃訪問手機商鋪
010-62081908
在線留言